Stock Comparison
KRYS vs REGN
Krystal Biotech Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$10.97B
$66.35B
P/E (TTM)
49.8
15.5
Forward P/E
54.6
14.1
Price/Sales
26.3
4.5
Price/Book
8.6
2.1
EV/EBITDA
54.8
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
53.90%
29.60%
Operating Margin
46.10%
20.70%
Return on Equity
19.90%
14.50%
Return on Assets
9.04%
6.13%
Growth (YoY)
Revenue Growth
31.90%
19.00%
Earnings Growth
52.50%
-7.20%
Price & Risk
Beta
0.5
0.2
52-Week High
$376.28
$818.90
52-Week Low
$130.50
$516.07
Analyst Target
$349.78
$833.31
Compare KRYS and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.